Renal transplant recipients (RTRs) have elevated oxidative stress and a high incidence of cardiovascular morbidity and mortality. Although recent studies do not support the use of antioxidant supplements as a cardioprotectant in the general population, evidence suggests that RTRs may represent individuals that would benefit from this therapy. RTRs have elevated oxidative stress probably caused by the immunosuppressive therapy, and although only a small number of studies have examined the effects of antioxidant supplementation in these patients, most have reported beneficial findings. This review discusses these studies along with the rationale for the use of antioxidant supplements in RTRs and a call for more research to investigate this important topic.
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in renal transplant recipients (RTRs). [1] [2] [3] [4] The underlying etiology of CVD in RTRs is multifaceted, with the traditional risk factors of hypertension, dyslipidemia, age, gender, and smoking partially predictive of outcome in these patients. 5 There is much interest in the role that oxidative damage may play in the pathogenesis of CVD in RTRs, with a number of studies reporting elevated markers of oxidative stress in these patients. 6 -14 It has been shown that the immunosuppressive therapy, in particular cyclosporine A (CsA), elevates oxidative stress through the production of reactive oxygen species during the drugs' biotransformation. 13, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] The use of antioxidant supplementation as a cardioprotectant has received much research attention in recent years. Although earlier observational studies reported significant decreases in CVD morbidity and mortality in individuals consuming antioxidants, 25, 26 these findings have not been supported in large scale, randomized, placebo controlled trials. There is evidence that antioxidant supplementation may be more important in individuals with elevated oxidative stress or compromised antioxidant defenses such as RTRs. 30 -32 Given this information, it is surprising that only five studies have investigated the use of antioxidant supplementation in RTRs. 11, 15, [33] [34] [35] This review discusses evidence of elevated oxidative stress in RTRs and describes the studies that have investigated the effects of antioxidant supplementation in RTRs.
Reactive Species and Oxidative Stress
Reactive species comprise both reactive oxygen species (ROS) and reactive nitrogen species (RNS) that are being constantly formed in the body. These reactive species have the capacity to damage cells or interrupt cellular processes and are implicated in numerous pathologic conditions, including cardiovascular disease. 36 -38 There are numerous chemical reactions that result in the formation of reactive species. The superoxide radical is constantly formed in the mitochondria when electrons passing through the electron transport chain leak from electron carriers, reducing oxygen to the superoxide radical. 39 It has been estimated that 2% of oxygen consumed forms reactive species through this process. 40 Like the mitochondria, microsomal and nuclear membranes also contain electron transport systems that result in the production of reactive oxygen species. For example, liver microsomes generate superoxide and hydrogen peroxide during detoxification processes. 41 Superoxide is unique in that it can lead to the formation of many other reactive oxygen species. 41 Normally, superoxide is short lived and converted enzymatically to hydrogen peroxide, 42 which, in turn, is converted enzymatically to water and oxygen. 43 If the superoxide radical or hydrogen peroxide comes into contact with iron or copper ions (Fe 2ϩ and Cu 2ϩ ) before they are eliminated, the hydroxyl radical (OH • ) may be formed. The hydroxyl radical is the most highly reactive of all free radicals. 44 Reaction of hydroxyl radicals with biological molecules sets off chain reactions that result in the formation of new radicals. 44 One hydroxyl radical can potentially result in the production of hundreds of organic free radicals. 39 Reactive species are also produced during formation of nitric oxide, 45 during catecholamine metabolism and nucleoprotein digestion. 40 Autooxidation of thiols, catecholamines, semiquinones, and hemoglobin also results in production of reactive oxygen species. 40 Although reactive species are essential for certain physiologic processes, when their concentration is raised beyond the capacity of the protective mechanisms, or when the protective mechanisms are faulty, they may induce molecular and cellular damage. Unsaturated fatty acids, proteins, and DNA are especially sensitive to free radical induced damage. 39 Antioxidants protect against damage from reactive species and com-prise both endogenous and exogenous compounds that form the antioxidant defense system. Oxidative stress is defined as an imbalance between the production of various reactive species and the antioxidant defense system such that the antioxidants are unable to cope with the production of reactive species. 46 Unsaturated fatty acids are susceptible to free radical attack because their double bonds attract the unpaired electron of the radical. Oxidative damage to unsaturated fatty acids alters their structure and makes them more hydrophilic. 47 Given that the cell membrane is composed of a significant proportion of phospholipids, free radical damage can result in the disturbance of normal membrane function.
Proteins are also susceptible to free radical attack. Oxidation of proteins because of free radical damage can lead to inactivation of enzymes, inadequate function of membrane channels and pumps, and an inability of hemoglobin to carry oxygen. Oxidative damage to proteins can therefore result in an inability of the cell to maintain metabolism and ionic gradients, leading to electrolyte and fluid imbalance. Indeed, extensive oxidative damage to proteins can result in cell death. 47 Given that free radicals can induce such cellular damage, it is not surprising that oxidative stress has been implicated in more than 50 diseases, such as the pathogenesis of atherosclerosis, inflammatory diseases, cancer, and certain neurologic disorders. 39 In addition, oxidative stress is also thought to participate in aging processes. 39 
Methods for Detecting Oxidative Stress
With evidence that oxidative stress is involved in various disease processes, many techniques have been developed to measure markers of lipid, protein, and DNA oxidation. A number of these techniques have been widely criticized for their lack of validity, and it is important to discuss these issues before examining relevant original investigations conducted upon RTR.
One of the most commonly used techniques for measuring lipid peroxidation has been the thiobarbituric acid (TBA) test to estimate malondialdehyde (byproduct of lipid peroxidation) concentration. The assay is popular because of its simplicity and low cost, and the test is appropriate for defined membrane systems (e.g., microsomes and liposomes), but its application to body fluids and tissue extracts has produced a host of problems. 48, 49 Indeed, it is widely recognized that considerable confusion about the role of peroxidation in human disease is a result of the inappropriate application of these tests to human material. 48 Of the five original investigations using antioxidants in renal transplant patients, 11, 12, 15, 33, 35 it is important to note that three of these used the TBA test to quantify plasma lipid peroxidation. 12, 15, 35 Recently, more robust measures of lipid peroxidation, such as the direct measurement of malondialdehyde using HPLC or the determination of isoprostanes with commercially available ELISA kits, have been accepted as valid and reliable assays. 50 However, to our knowledge, there has yet to be a published study on this topic using these techniques.
Another method used to measure oxidative stress, or more accurately the potential to undergo oxidative stress, is to determine the lag time in the oxidation of serum or isolated low density lipoprotein (LDL). In these assays, copper is generally used to activate the oxidation process; however, the use of these ions has been criticized for their limited validity in vivo. 51 In addition, it has been suggested that the prolonged procedures required to purify LDL may remove antioxidants that may protect LDL in the circulation. 48 Furthermore, the usefulness of assessing the susceptibility of whole serum to oxidation requires clarification of the relationship between lipid oxidation in plasma and LDL oxidation in the vessel wall. 48 In the five original investigations using antioxidants in renal transplant patients, 11, 12, 15, 33, 35 three of these measured the susceptibility of serum or LDL to copper induced oxidation. 11, 15, 35 
Antioxidants
The antioxidant defense system comprises compounds that are either enzymatic or nonenzymatic. Primary enzymatic defenses include superoxide dismutase, catalase, and glutathione peroxidase. In general, these systems are responsible for converting superoxide radicals and hydrogen peroxide to water and oxygen. The nonenzymatic antioxidants are responsible for scavenging reactive species that escape the antioxidant enzymes. Well known nonenzymatic antioxidants include glutathione and the nutritional antioxidants vitamin E, vitamin C, and beta-carotene. 39 In addition to the enzymatic and nonenzymatic defense systems, metal ion sequestration is an important antioxidant defence. 39 Transitional metals such as iron and copper can cause the formation of free radicals. If these metals are bound, thereby removing them from solution, radical formation can be prevented. In the body, iron is stored as ferritin and transported as transferrin. The capacity of transferrin to bind iron in the plasma is three times greater than that required, so under normal circumstances, there are no free iron ions in the plasma. Ceruloplasmin binds copper in the extracellular compartment, also preventing free copper ions from circulating in the plasma. 52 
Oxidative Stress and Cardiovascular Disease
Although the role that oxidative stress plays in the pathogenesis of CVD has yet to be proven, the general consensus is that oxidation of LDL is a key event during the development of atherosclerosis. 53 Furthermore, innumerable new proatherogenic effects have been attributed to oxidative stress. For example, there is evidence that oxidative stress may be involved in CVD through the pathogenesis of endothelial dysfunction 11, 54 or platelet aggregation. 54 Several lines of evidence support the notion that LDL oxidation is involved in CVD: (1) oxidized LDL has been found in atherosclerotic lesions but not in unaffected arteries; 55 (2) cells present in the subendothelial space of a developing lesion can oxidise LDL in vitro; 56 (3) autoantibodies against oxidized LDL are found in human plasma; 57 and (4) administration of lipid soluble antioxidants, including vitamin E, reduces atherogenesis in animals 58 and increases the resistance of LDL from humans to oxidation in vitro. 59 
Immunosuppressants and Oxidative Stress
There is overwhelming evidence that immunosuppressant treatment increases oxidative stress with the majority of re-search focusing upon cyclosporine. In heart 60 and renal transplant recipients, 10, 22, 54, 61, 62 cyclosporine administration is associated with elevated markers of oxidative stress. Indeed, it has been shown that, compared with other immunosuppressants such as prednisone, 63 azothiaprine, 64 and tacromlimus, 65 cyclosporine results in greater oxidative stress. 8, 65, 66 The mechanism through which CsA elevates oxidative stress is believed to be via the drugs' metabolism and its effect upon cytochrome P-450. 19, 21, 54, [67] [68] [69] Work by Yoshimura and associates 70, 71 found that CsA administration induces an increase in cytochrome P-450 several fold. As increased cytochrome P-450 activity causes ROS production, 16, 72 a CsA mediated increase in cytochrome P-450 activity would explain the elevated ROS production in patients taking the medication.
Antioxidant Supplementation and Cardiovascular Disease in the General Population
In the mid 1990s, a number of observational studies reported the importance of dietary antioxidants in primary prevention of coronary heart disease. These included the Nurses' Health Study, 26 the Health Professionals' Follow-Up Study, 25 and the second National Health and Nutrition Examination Survey. 73 In addition, secondary prevention of CVD was reported in a placebo controlled, randomized trial from the University of Cambridge. Antioxidant supplementation with 400 -800 IU/day vitamin E for approximately 500 days resulted in a 46% reduction in cardiovascular death and fatal myocardia infarction (MI) and a 77% decrease in nonfatal myocardial infarction (MI) in patients with angiographically determined CAD. 74 However, recent prospective, controlled clinical trials of antioxidants, including the Heart Outcomes Prevention Evaluation (HOPE) trial, 27 Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione trial, 28 and the Heart Protection Study (HPS), 29 have not supported the initial postulate that supplementary antioxidants will protect against CVD in the general population. Based upon these recent studies, the use of supplementary nutritional antioxidants, such as vitamin E, vitamin C, and beta carotene, is not indicated in the general population. 75 
The Use of Antioxidant Supplements in Renal Transplant Recipients
The findings that RTRs have elevated markers of oxidative stress have led only a small number of studies to investigate the effects of antioxidant supplementation in these patients. A comprehensive search of the literature found five studies that have supplied antioxidants to renal transplant patients ( Table  1) . The antioxidants were given by infusion, 15 in tomato juice, 35 or as oral tablets. 11, 12, 33 In the first documented study to investigate the effects of antioxidants in RTRs, Rabl and colleagues 15 completed an acute dose study looking at the effects of a preoperative multivitamin infusion upon markers of lipid peroxidation and reperfusion damage during kidney transplantation. The study was a randomized, controlled trial, where 30 patients scheduled to receive kidney transplantation were randomly divided into either the supplementation (n ϭ 16) or the control group (n ϭ 14). Blood samples were taken from both groups 30 minutes before and 1, 2, 3, and 4 hours postoperatively. The 12 Noncontrolled trial 6 months 1. RTR without CR (n ϭ 34) 2. RTR with CR ϩ Vitamin E (500 mg ␣-tocopherol daily, 6 months) (n ϭ 23)
1. MDA levels (estimated from TBA test) were higher in group 2 compared with group 1. 2. MDA decreased in group 2 post supplementation. 3. Increase in antioxidant defence mechanism post supplementation. Williams et al. 11 Randomized, placebo controlled, crossover trial 24 hours RTR supplemented vitamin C (n ϭ 13) crossover design 1. Plasma vitamin C levels and endothelium dependent dilation increased post supplementation. 2. Vitamin C was also associated with an increase in the lag time in serum oxidation.
Tx, treatment; RTR, renal transplant recipient.
treatment group received 2 ampules of Omnibionta diluted in 500 ml sodium chloride solution intravenously 30 minutes before initiation of allograft transplant (and reperfusion), immediately after the 30 minute before blood draw. The Omnibionta ampule contained an antioxidant mixture, which included ␣-tocopherol acetate, D-␣-tocopherol, and ascorbate. Lipid peroxidation was quantified with the TBA test to estimate malondialdehyde (MDA) content of plasma. In the control group plasma MDA peaked 1 hour after the onset of reperfusion at (mean Ϯ SD) 1.46 Ϯ 0.22 nmol/ml compared with the baseline level of 0.74 Ϯ 0.26 (p Ͻ 0.001). The antioxidant group did not show an increase in MDA but decreased this marker by 20% compared with baseline values. The authors concluded that a multivitamin infusion could play a significantly useful and protective role in the reduction of lipid peroxidation from reperfusion during kidney transplantation. Although the validity of the TBA test has been widely criticized, these findings agree with numerous studies using various oxidative stress markers reporting that antioxidants are effective at preconditioning tissue against ischemic reperfusion injury. 76 -78 A longer-term effect of antioxidant supplementation was investigated when Hussein et al. 33 used dietary selenium (0.2 mg/day) for 3 months to activate the glutathione system and investigate the relationship between this system and plasma and LDL oxidation in six RTRs. It is important to note that these patients had plasma that was more susceptible to lipid peroxidation compared with control subjects. Copper sulphate (CuSO 4 ) induced LDL oxidation was also significantly increased in the patients compared with control subjects. Selenium treatment resulted in an impressive 50% reduction in induced plasma lipid peroxidation. The susceptibility of the patients' plasma to lipid peroxidation returned toward baseline values 3 months after termination of the selenium treatment. Similar results, although less pronounced (only 15% reduction), were obtained for CuSO 4 induced LDL oxidation. Analyses of the patients' red blood cell (RBC) glutathione system revealed low levels of reduced glutathione and decreased activities of RBC glutathione peroxidase and glutathione reductase by 23%, 18%, and 20%, respectively, in comparison with the control patients' RBC. Selenium treatment resulted in a significant elevation of RBC glutathione peroxidase and glutathione reductase activities and in reduced glutathione content by 64%, 57%, and 11%, respectively; this effect was also paralleled by a 39% reduction in the RBC oxidized glutathione content. Upon termination of the selenium treatment, and after 3 months on placebo, all of these values of the glutathione system elements returned toward baseline levels. These findings indicate that the glutathione antioxidant system may be compromised in RTRs, and compounds that increase the capacity of the system, such as selenium, may be helpful to these patients. Further research in this area should include the assessment of dietary selenium intake and the measure of circulating selenium.
The effects of long-term (6 months) vitamin E supplementation (500 mg/day) in RTR in the presence or absence of chronic rejection (CR) was studied by Vela et al. 12 The subject population of 57 renal transplant recipients was divided into two groups, those with CR (group 1, n ϭ 23) and those without CR (group 2, n ϭ 34). Chronic rejection was identified and substantiated by tissue biopsy. Oxidative stress was quantified with the TBA test. In addition, RBC superoxide dismutase (SOD), ␣-tocopherol, and glutathione were measured along with plasma ␣-tocopherol and glutathione peroxidase (GPX). In the patients with CR, MDA was significantly higher compared with patients without CR. This oxidative stress was associated with a nonsignificant decrease in main antioxidant defense mechanisms, RBC vitamin E, glutathione, SOD, and GPX. Vitamin E supplementation resulted in a significant increase in plasma vitamin E, compared with presupplementation, and MDA decreased. Of interest was the finding that, during the 6-month period, renal function remained stable as demonstrated by creatine and diethylenetriaminepentaacetic acid (DTPA) clearances. The benefits of antioxidant supplementation upon renal function in RTRs is currently being investigated by our laboratory with our initial findings supporting the improvement in renal function finding. 79 Currently, there is much interest in the benefits of vitamin E in renal populations. The Secondary Prevention with Antioxidants of Cardiovascular Events (SPACE) study gave 800 IU/day of vitamin E to patients on hemodialysis and reported a 17% decrease in mortality. 80 The differential effect of vitamin E in renal patients compared with the general population (as described previously) may because of recent evidence concerning differences in vitamin E metabolism between healthy individuals and renal patients. 81 Himmelfarb et al. 82 showed that there is a 6-to 10-fold higher increase in the formation of major metabolites of vitamin E: carboxyethyl-hydroxychromans (CEHC). These compounds have significant antioxidant activity, are water soluble, and are known to be excreted via the kidneys. The speculation is that the beneficial effects of vitamin E in renal patients shown in the SPACE study and perhaps the work by Vela et al. 12, 34 compared with the lack of effects in healthy individuals may be explained by a decreased excretion of the CEHC and therefore increased circulation and bioavailability of these compounds. This is an exciting area for future research.
Tomato juice was given to 15 RTRs, and changes in plasma levels of the antioxidant lycopene and serum indices of oxidative stress were recorded in a randomized placebo controlled crossover study. 35 Two markers of lipid peroxidation were used to quantify oxidative stress in the serum: (1) fluorescent lipid oxidation products (FLOP) and (2) the TBA test for MDA. Also, the lag time of CuSO 4 induced LDL oxidation was determined. Supplementation for 4 weeks with the tomato juice significantly increased plasma lycopene; however, there were no significant differences in serum FLOP, TBA, and the resistance of LDL to oxidation. Indeed, although the use of tomato juice has been reported to protect against oxidative stress in some studies, 83, 84 including an investigation in diabetics from the same research group, 85 the effects appear to be varied across different pathologies. 86, 87 Although, changes in biochemical markers of oxidative stress may be important in determining effects on cardiovascular health, only one acute study has looked at changes in functional cardiovascular parameters. Williams et al. 11 used a randomized, placebo controlled, double blind, crossover design to evaluate the effects of a single 2 g dose of Vitamin C upon endothelial function in 13 RTRs. The measures were made 2 hours before and after supplementation. Oxidative stress was determined by measuring the susceptibility of weak serum to CuSO 4 induced oxidation. One dose of vitamin C resulted in significant increases in plasma vitamin C, increased susceptibility of serum to oxidation, and improved endothelium dependent dilation. Of all studies to date, these data provide the best evidence that an antioxidant may provide a functional as well as a biochemical benefit to RTRs. Further studies are needed to confirm these findings and investigate the effects that other antioxidants may have in these patients.
Conclusion
Patients with high levels of oxidant stress or depletion of natural antioxidant defense systems, such as RTRs, may be the most likely to benefit from antioxidant therapy. Currently, there are only a small number of published studies evaluating the effects of antioxidant supplementation in RTRs. Three of these studies were longer-term investigations (1-6 months), and two were using a single dose. Apart from one long-term study that supplemented with tomato juice, the other four studies reported decreases in markers of oxidative stress. It is important to note that the most recent study, using a single vitamin C supplement, also reported a concomitant improvement in vascular function with the antioxidant supplementation, further supporting the benefits in these patients. More research is required to determine the efficacy of antioxidant supplements in RTR, with large scale, prospective, placebo controlled trials with clinical end-points urgently needed.
